TCL Archive Phase III Trial In Recurrent Disease Shows Lower Risk of Progression or Death by 34% June 28, 2013
TCL Archive Cooperative group Outreach Extended Three ears, Gets Extra $1 Million, Up to Four More Awards October 28, 1983
TCL Archive Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer April 24, 2009
TCL Archive In Vote Against Tarceva As Maintenance, ODAC Seeks Stronger Survival Benefit December 18, 2009
